QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Business Wire
Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them in AfricaQIAprep& Plasmodium Kit enables streamlined detection of five malaria-causing parasites for epidemiological research and surveillanceNovel QIAGEN assays support mixed-infection tracking, vaccine impact assessment and malaria control strategies in regions with limited healthcare infrastructure VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep& Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.This new solution combines sample preparation and quantitative PCR (qPCR) into a single workflow, providing a rapid and accessible tool for detecting malaria-causing parasites from blood samples.Malaria remains one of the world’s most pressing public health challenges, particularly in tropical and subtropical regions. The disease i
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Syndromic Multiplex Diagnostics Market Size to Hit USD 4.13 Billion by 2032, Growing at a CAGR of 4.71% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million [Yahoo! Finance]Yahoo! Finance
- QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 MillionBusiness Wire
- Qiagen (NYSE:QGEN) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Are Investors Undervaluing Qiagen N.V. (NYSE:QGEN) By 24%? [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 11/4/25 - Beat
QGEN
Sec Filings
- 11/12/25 - Form SCHEDULE
- 11/6/25 - Form 6-K
- 11/6/25 - Form 6-K
- QGEN's page on the SEC website